At Janssen, we’re creating a future where the disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: “Take what you find here and make it better and better.” More than 145 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.
At Merz Aesthetics, we are family-owned since 1908 and treat customers, patients and employees like family. It drives our unique connection with healthcare professionals, and it’s what makes their success our success. For us it’s personal — listening, advising, supporting and celebrating them as we pursue a shared vision to help the world look better, feel better and live better.
AbbVie’s identity is shaped by the work we do – producing innovative medicines, continually investing in our pipeline, and giving back to create healthier, more vibrant communities. Most of all, this identity has been shaped by the beliefs we share that have emerged organically since AbbVie began.
We’re focused on sustainable growth and addressing the worlds pressing health challenges.
We do more than just treat diseases—we’re committed to new thinking and approaches that make a greater impact.
Eucerin is the dermatologist-recommended skin care brand based on honest skin science. It sustains and restores skin’s health and gives you the confidence of a healthy radiant skin. With its medical knowledge, skin competence and cosmetic dedication Eucerin is the one skin care brand that delivers a holistic “dermo-cosmetic” approach.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world. Find out more at.
The L’Oréal Active Cosmetics division is composed of three pillar brands: Vichy, La Roche-Posay, SkinCeuticals and CeraVe. Each backed by groundbreaking medical technologies, they cater to a variety of skin conditions ranging from skin disease, to aging and acne. The products under this portfolio are developed based on medical research and supported by scientific trials, that prove their effectiveness in achieving desired results.
The division is currently a world leader in dermocosmetics, endorsed by a variety of health professionals to include dermatologists, pediatricians, and cosmetic doctors. Each plays a vital part in the success of the four brands and their products, that are available to patients after prescription. The medical professionals that support our brands, are an extended part of the L’Oréal Active Cosmetics family, allowing our technologies to reach patients and impact their lives in a positive way.
As a leading medical device provider in the MENA region, AMICO Group’s mission transcends beyond the horizon of mere product offerings or trade services. Working proactively with our strategic partners, we constantly aim to elevate the building blocks of our services as a consummately specialized total solution provider.
At AMICO Group, we have comprehensive knowledge of the Middle East markets, the emerging industry trends, economic changes and cultural diversity throughout the region.
‘Think globally, act locally,’ is an accurate representation of our corporate culture. Local challenges will require local solutions, however, without access to global resources the local solutions may well be a compromise. If highly specialized services are readily available in one country, yet unavailable in another, or if financing is of a shortage in a certain country, supportive solutions may be obtained from our corporate center.
Through our network, we help create ‘centers of excellence’ combining the expertise of our regional and local offices. In short, we place a high value in our relationships with our business partners and to committing long-term mutual success. By unifying the diverse marketplace of the Middle East, Amico gives international companies an unrivaled network and local know-how for effectively driving Middle East strategies for our business partners.
Central Circle Company (“CCC”) was first established in 1979, specifically to provide medical equipment and turnkey solutions for various medical institutions in the State of Kuwait. CCC’s main objective, subsequent to the acquisition is to promote ethical transparency, innovation and excellence within the medical industry.
Dr. Ziad Alalyan, a Consultant and Fellow of the College of Emergency Medicine and Member of the Royal College of Surgeons, UK and Scotland, was appointed as Partner and Chief Executive Officer (“CEO”) of CCC in 2014, following its acquisition by the Senior Partner and Dr. Alalyan. During his short tenure as CEO, Dr. Alalyan has taken CCC to the upper echelons of the medical industry, coupled with a veracious appetite for global expansion and excellence.
CCC has experienced significant growth in all sectors, specifically in pharmaceutical products. The management however, are now exploring other avenues of enhancing the services CCC offers to end-users i.e. utilising Artificial Intelligence (“AI”) to generate automated medical services. The company also has ambitious plans to venture into independent healthcare centres, with a primary emphasis on offering complete medical services i.e. diagnosis, operative procedures, follow up and after care.
Medica Trading LLC is a leading Dubai-based medical trading company, committed to providing aesthetics, dermatology, and dental machines and products in the UAE and operating countries which meet the expectations of the interested parties. The company aims for growth and prosperity through the development of confidence and positive perception in the organization and market place. The implementation, maintenance, and continuous improvement of a quality management system stems from the management’s commitment towards achieving its quality and strategic objectives, relying on the active participation, cooperation, and dedication from all staff. The management will make sure that staff at all levels understands the importance of complying with the quality policy as we maintain our position as the leading skin care products and aesthetic equipment distributor in MENA and Southeast Asia.
AL NAJAH AL MOTEALK GENERAL TRADING Company was founded in 2012 based in Dubai, registered as Limited Labiality Company according to the Laws of United Arab Emirates.
AL Najah was established to cater the progressive demand of the Gulf Region market by offering an excellent import and export services to the public and the governmental sectors.
Al Najah has rapidly built strong relationships with both manufactures, suppliers and end customers within a transparent professional environment which benefits all parties.
Ego was founded when a young chemist, Gerald Oppenheim, and his wife, Rae, a nurse, saw a need for products to restore and maintain healthy skin. In the laundry of their suburban Melbourne home they developed Ego Pine Tar Bath Solution, later called Pinetarsol, which remains one of Australia’s most widely used inflammation treatments.
Ever since Ego has continued to research and develop products and treatments to care for and meet the skin needs of all people. Gerald Oppenheim passed away in 1995 leaving his legacy, Ego, to the family. His sons, Alan Oppenheim the Managing Director, and David Oppenheim both sit on the Board of Directors. As does Dr Jane Oppenheim, Alan’s wife, who is the Scientific and Operations Director.
Proudly Australian-owned, Ego Pharmaceuticals has led the way in the development, manufacture and marketing of innovative skincare products for 60 years. Our mission is to exist for people who want healthy skin. Ego is the specialist in skincare, backed by science. We make our products in Australia for the people of the world. We provide consistently high quality products, underpinned by heritage and integrity.
From its inception as a family business in 1953, Ego has grown to become a world leader, producing a comprehensive skin and health care range for sale in Australia and around the world. Our reputation is built on consistently delivering effective, high-quality and innovative products to meet a diverse range of needs, and we are committed to creating the best possible skin therapies for our customers.
We have hundreds of testimonials that tell us people trust Ego to help care for their skin every day.
The name ‘Ego’ is an acronym for Erwin and Gerald Oppenheim. Dr. Erwin Oppenheim, Gerald’s father was a dermatologist.
As a leading provider of high-quality medicines, our strategy is to make healthcare more accessible by delivering more from our strong foundation, building a portfolio that anticipates future health needs and inspiring and enabling our people.
Our brand promises
Better health. Within reach. Every day. By creating high-quality products and making them accessible to those who need them we are helping to shape a healthier world that enriched all of our communities.
Founded more than 40 years ago, our purpose has always been to provide high-quality, affordable medicines to the people who need them. Based on the solid foundation we have built; we will continue to innovate and find practical solutions to transform the lives of the millions of people we serve.
A state-of-the-art manufacturing company established in Amman Jordan in the year 2005.
Jerash Pharma is specialized in manufacturing liquid and semisolid dosage forms, and hospital disinfectants. Jerash Pharmaceuticals is part of Khraim Group which is owned and run by Khraim family.
Striving For Better Healthy Life By Introducing Our Innovative, Distinctive And High-Quality Products.
Lead The Way To The Future Of Improving Life.
Our Products: We…..
NeoCell® – is a US-based trusted brand of collagen since 1998. NeoCell® has been developing and manufacturing all-natural, premium anti-aging formulas for over 24 years. Its products range are naturally based, not synthetic, and are designed to promote youthful health, beauty, and total body wellness.
Backed by science, NeoCell® products support in illuminating your beauty from the inside out, helping magnify your brilliance, improve your collagen, and awaken your inner beauty.
RegenLab® is a leading innovator of medical products for the preparation of platelet-rich plasma. Regen Lab provides expertly designed & patented Medical Devices for platelet-rich plasma preparations, CE certified, registered by most national agencies worldwide. Regen Lab remains committed to providing products of the highest quality and safety, as well as protecting customers through enforcement of its intellectual property rights.
SAWA MEDTEC is a premier, young and dynamic medical company focused on supplying, selling and marketing for an innovative aesthetic medical products across the middle east countries.
SAWA MEDTEC, with more than 10 years of experience, provides a diversified range of high quality aesthetic medical products.
SAWA MEDTEC, is building the future together with its strategic partners with focus on commitment, growth, innovation and product quality.
The Oman Dermatology Society (ODS) was established in Muscat in 2006, as a national body for dermatology. This was within the main tertiary care centre of Al Nahdha Hospital where the Department of Dermatology was first established in 1972.
ODS was initiated to address dermatological resources in healthcare services for diagnosis and management of common skin diseases in Oman. The society was conceptualized to gather all dermatologists and venereologists to share and discuss the clinical practice, education and research relevant in dermatologic medicine, surgery and related discipline.
Oman Dermatology Society is affiliated to Oman Medical Association and is under the patronage of Ministry of Social Development. The Society’s aim is to cater the academic needs of all the dermatologists in the Ministry of Health, Government and private sectors. Members are encouraged to conduct research and studies inclined in the field of specialization.
The Dermatopathology Society of India was set up in 1997 with the aim of promoting education, research and patient care in the subject and to provide a meeting ground for people interested in this specialty. We currently have about 450 members, mainly from India but also from other countries including Sri Lanka, Nepal and United Kingdom. We have an active Facebook page, with a large community that participates actively in our twice monthly dermatoathology quizzes and other discussions.
DSI hold regular meetings and CME events on our own and in collaboration with pathology and dermatology associations. We publish the Indian Journal of Dermatopathology and Diagnostic Dermatology, in collaboration with the Indian Association of Dermatologists, Venereologists and Leprologists, Karnataka branch. DSI seek to connect with other dermatopathologists in our neighborhood and also at the regional and global level.
The International Society of Dermatopathology (ISDP) was founded in 1979 by Helmut Kerl, MD; Gérald E. Piérard, MD; Jorge Sánchez, MD; and the late A. Bernard Ackerman, MD, who also served as the ISDP’s first president. The International Society of Dermatopathology, Inc, was incorporated in 1994, and classified as not-for-profit.
The aims and objectives of the ISDP are to increase knowledge of the structure and function of the skin and of diseases of the skin by microscopy. The Society intends to promote friendship and scientific exchanges among its members of different countries; to sponsor international and regional meetings; and to sponsor educational events.